• Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987;316:285–91. Historical interest. The authors thought that this was a form of maturity-onset diabetes of youth.
CAS
Article
Google Scholar
•• Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IP, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush Diabetes. Diabetes. 1994;43:741–5. Initial detailed description of what is now classic ketosis-prone diabetes of black patients with type 2 diabetes. Key features are new-onset diabetes presenting with ketoacidosis and severe hyperglycemia with negative GAD and anti-islet antibodies.
CAS
Article
Google Scholar
• McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA. Near-normoglycaemic remission in African Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med. 2001;18:10–6. Characterizes return of β-cell function after treating severely hyperglycemic patients to normoglycemia.
CAS
Article
Google Scholar
•• Umpierrez GE, Casals MMC, Gebhart SSP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African Americans. Diabetes. 1995;44:790–5. Describes ketosis-prone diabetes in a second black population and shows initial beta cell unresponsiveness to glucose and severe insulin resistance.
CAS
Article
Google Scholar
•• Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline J-P, Kevorkian J-P, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of Sub-Saharan African Origin. Diabetes. 2004;53:645–53. Compares ketosis-prone African blacks who remain insulin dependent to those who have become insulin independent.
CAS
Article
Google Scholar
Maldonado M, Hampe CS, Gaur LK, D’Amico S, Iyer D, Hammerle LP, et al. Ketosis-prone diabetes: dissection of a heterogenous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003;88:5090–8.
CAS
Article
Google Scholar
Tan H, Zhou Y, Yu Y. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents—a teaching hospital-based analysis. Diabetes Res Clin Pract. 2012;97:306–12.
Article
Google Scholar
Iwasaki I, Hamamoto Y, Kawasaki Y, Ikeda H, Honjo S, Wada Y, et al. Japanese cases of acute onset diabetic ketoacidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine. 2010;37:286.
CAS
Article
Google Scholar
Gupta RD, Ramachandran R, Gangadhara P, Anoop S, Singh SH, Satyaraddi A, et al. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ ketosis-prone diabetes (KPD): the first identified cohort amongst Asian Indians. J Diabetes Complicat. 2017;31:1401–7.
Article
Google Scholar
Zhang M, Li Y, Cui W, Yang P, Li H, Sheng C, et al. The clinical and metabolic characteristics oy young-onset ketosis-prone type 2 diabetes in China. Endocr Pract. 2015;21:1364–71.
Article
Google Scholar
Gosmanov AR, Smiley D, Robalino G, Siqueira JM, Peng L, Kitabchi AE, et al. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemic remission. Diabetes Care. 2010;33:854–60.
CAS
Article
Google Scholar
Banerji MA, Chaiken RL, Lebovitz HE. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes. 1996;45:337–41.
CAS
Article
Google Scholar
Choukem S-P, Sobngwi E, Boudou P, Fetita L-S, Porcher R, Ibrahim F, et al. β- and α-cell dysfunction in Africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care. 2013;36:118–23.
CAS
Article
Google Scholar
Umpierrez GE, Sniley D, Rabalino G, Peng L, Gosmanov AR, Kitabchi AE. Lack of lipotoxicity effect on β-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care. 2010;33:626–31.
CAS
Article
Google Scholar
Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, DJahmeni E, et al. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med. 2017;34:426–31.
CAS
Article
Google Scholar
Sobngwi B, Gautier J-F. Adult-onset idiopathic type 1 diabetes or ketosis-prone type II diabetes: evidence to revisit diabetes complications. Diabetologia. 2002;45:283–5.
CAS
Article
Google Scholar
• Banerji MA, Lebovitz HE. Remission in non-insulin-dependent diabetes mellitus: clinical characteristics of remission and relapse in black patients. Medicine. 1990;69:176–85. Black patients can present with new-onset diabetes with severe hyperglycemia with or without ketoacidosis.
CAS
Article
Google Scholar
Grabacka M, Pierzchalska M, Dean M, Reiss K. Regulation of ketone body metabolism and the role of PPARα. Int J Mol Sci. 2016;17:2093–117.
Article
Google Scholar
Geisler CE, Renquist B. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 2017;231:1–24.
Article
Google Scholar
Kanikarla-Marie P, Jain SK. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. Free Radic Biol Med. 2016;95:268–77.
CAS
Article
Google Scholar
Kersten S. Integrated physiology and systems biology of PPARα. Mol Metab. 2014;3:354–71.
CAS
Article
Google Scholar
Patel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, et al. Pathogenesis of A-B+ ketosis-prone diabetes. Diabetes. 2013;62:912–22.
CAS
Article
Google Scholar
Ramos-Roman MA, Burgess SC, Browning JD. Metabolomics, stable isotopes, and A-B+ ketosis-prone diabetes. Diabetes. 2013;62:682–4.
CAS
Article
Google Scholar
Banerji MA, Chaiken RL, Lebovitz HE. Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes. 1995;44:466–70.
CAS
Article
Google Scholar
Umpierrez GE, Clark WS, Steen MT. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care. 1997;20:479–83.
CAS
Article
Google Scholar